Literature DB >> 5485144

A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474.

B N Singh, E M Vaughan Williams.   

Abstract

1. Both MJ 1999 and AH 3474 protected guinea-pigs anaesthetized with urethane against ouabain-induced ventricular fibrillation.2. MJ 1999 had 1/90, and AH 3474 1/30, of the activity of procaine in reducing the height of the action potential of frog sciatic nerve.3. MJ 1999 and AH 3474 reduced the rate of rise of intracellularly recorded action potentials at concentrations in excess of 160 x 10(-6)M (50 mg/l.). It was concluded that direct depression of depolarization could have contributed little to the protection against ouabain-induced fibrillation.4. MJ 1999, but not AH 3474, greatly prolonged the duration of the action potential in acute experiments on isolated atrial and ventricular muscle, and prolonged the Q-Tc interval of the electrocardiogram in anaesthetized guinea-pigs. It is suggested that this effect contributes to anti-arrhythmic activity.5. At concentrations up to 80 x 10(-6)M AH 3474 had positive chronotropic and inotropic effects on isolated rabbit atrial muscle, but at higher concentrations these were superseded by negative effects. MJ 1999 was depressant at all concentrations studied, the threshold concentrations being 19 x 10(-6)M for chronotropic, and 162 x 10(-6)M for inotropic effects.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5485144      PMCID: PMC1702723          DOI: 10.1111/j.1476-5381.1970.tb09893.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists.

Authors:  P M Lish; J H Weikel; K W Dungan
Journal:  J Pharmacol Exp Ther       Date:  1965-08       Impact factor: 4.030

2.  Inotropic and metabolic effects of three beta-adrenergic receptor blocking drugs on isolated rabbit left atria.

Authors:  J V Levy; V Richards
Journal:  J Pharmacol Exp Ther       Date:  1965-12       Impact factor: 4.030

3.  Cardiovascular pharmacology of two new beta-adrenergic receptor antagonists.

Authors:  H C Stanton; T Kirchgessner; K Parmenter
Journal:  J Pharmacol Exp Ther       Date:  1965-08       Impact factor: 4.030

4.  Evaluation of the cardiac effects of several beta adrenergic blocking agents.

Authors:  J R Blinks
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

5.  A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.

Authors:  J R Schmid; C Hanna
Journal:  J Pharmacol Exp Ther       Date:  1967-05       Impact factor: 4.030

6.  Myocardial and local anesthetic actions of beta-adrenergic receptor blocking drugs: relationship to physicochemical properties.

Authors:  J V Levy
Journal:  Eur J Pharmacol       Date:  1968-02       Impact factor: 4.432

7.  Inhibition of cardiac chronotropic action of isoproterenol by Sotalol (MJ 1999) in rat, dog and man.

Authors:  P M Lish; M V Shelanski; J A LaBudde; W R Williams
Journal:  Curr Ther Res Clin Exp       Date:  1967-06

Review 8.  The structure-activity relationships of beta adrenergic drugs and beta adrenergic blocking drugs.

Authors:  E J Ariëns
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

9.  Inhibition of sympathomimetic effects on the cardiovascular system by 4-(2-isopropylamino-1-hydroxyethyl)methanesulfonanilide hydrochloride (MJ 1999).

Authors:  P Aramendía; A J Kaumann
Journal:  J Pharmacol Exp Ther       Date:  1967-02       Impact factor: 4.030

10.  Effect of tetrodotoxin on membrane currents in mammalian cardiac fibres.

Authors:  J Dudel; K Peper; R Rüdel; W Trautwein
Journal:  Nature       Date:  1967-01-21       Impact factor: 49.962

View more
  68 in total

Review 1.  Mechanisms of antiarrhythmic drug actions and their clinical relevance for controlling disorders of cardiac rhythm.

Authors:  Uma Srivatsa; Nitin Wadhani; Bramah N Singh
Journal:  Curr Cardiol Rep       Date:  2002-09       Impact factor: 2.931

Review 2.  A prolonged QTc interval. Is it an important effect of antiarrhythmic drugs?

Authors:  F A Fish; D M Roden
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Nov-Dec

3.  Role of slow delayed rectifying potassium current in dynamics of repolarization and electrical memory in swine ventricles.

Authors:  Linyuan Jing; Kathleen Brownson; Abhijit Patwardhan
Journal:  J Physiol Sci       Date:  2014-03-30       Impact factor: 2.781

4.  Antiarrhythmic drug research.

Authors:  M J A Walker
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 5.  Antiarrhythmic drug classifications. A critical appraisal of their history, present status, and clinical relevance.

Authors:  S Nattel
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

6.  Interaction of different potassium channels in cardiac repolarization in dog ventricular preparations: role of repolarization reserve.

Authors:  Péter Biliczki; László Virág; Norbert Iost; Julius Gy Papp; András Varró
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

7.  Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Comparison with disopyramide and digoxin in a randomised trial.

Authors:  T J Campbell; T P Gavaghan; J J Morgan
Journal:  Br Heart J       Date:  1985-07

8.  Effects of the chromanol HMR 1556 on potassium currents in atrial myocytes.

Authors:  Ralph F Bosch; Alexander C Schneck; Saskia Csillag; Bernd Eigenberger; Uwe Gerlach; Joachim Brendel; Hans J Lang; Christian Mewis; Heinz Gögelein; Ludger Seipel; Volker Kühlkamp
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-11       Impact factor: 3.000

9.  Beta-adrenoceptor blockade and atrio-ventricular conduction in dogs. Role of intrinsic sympathomimetic activity.

Authors:  J F Giudicelli; F Lhoste
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 10.  Novel approaches for pharmacological management of atrial fibrillation.

Authors:  Joachim R Ehrlich; Stanley Nattel
Journal:  Drugs       Date:  2009       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.